$9.420
-0.205 (-2.18%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PHAR Prediction & Forecast by Similar Chart Analysis
Alphio's PHAR stock price prediction model matches the current Pharming Group NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.43 (+0.72%). The 1-week path is $9.47 (+1.14%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Pharming Group NV Stock?
Pharming Group NV is currently not a strong buy due to its low RSI of 40.977, indicating potential weakness, and a significant forward P/E of 212.766, suggesting overvaluation. However, the recent FDA approval for Joenja and a price target from analysts that is significantly higher than the current price of $10.47 indicate potential upside. The main risk is the disappointing last earnings report with an EPS surprise of -90% which could affect investor confidence.
PHAR stock price ended at $9.42 on Friday, after losing -2.18%
Pharming Group NV (PHAR) last closed at $9.36, losing -2.80%. These facts feed the 1-day and 1-week PHAR price prediction above.
Forecast Drivers
Pharming Group NV (PHAR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PHAR, ranked by similarity.
Seasonality analysis for PHAR
Historically the probability of a positive October return for PHAR is 39.66%. January offers the highest probability of a positive month at 59.02%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PHAR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $10.21 | $10.37 | $13.00 | +10.75% |
| Nov 2026 | $11.69 | $11.94 | $11.95 | +27.51% |
| Dec 2026 | $9.43 | $10.15 | $11.40 | +8.41% |
In 2026, Pharming Group NV (PHAR) is projected to range from $9.43 to $13.00.
Pharming Group NV 2026 monthly forecast
In Oct 2026, Pharming Group NV is projected to average $10.37, with a low of $10.21 and high of $13.00.
In Nov 2026, Pharming Group NV is projected to average $11.94, with a low of $11.69 and high of $11.95.
In Dec 2026, Pharming Group NV is projected to average $10.15, with a low of $9.43 and high of $11.40.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.